Perfil
Reid P.
Bissonnette currently works at Xenetic Biosciences, Inc., as Head-Translational Research & Development.
Dr. Bissonnette also formerly worked at Ligand Pharmaceuticals, Inc., as Associate Director, Huyabio International LLC, as Vice President-Pharmacology, Targazyme, Inc., as Vice President-Immuno-Oncology, and Arrivent BioPharma, Inc., as Head-Non-Clinical Research.
Dr. Bissonnette received his undergraduate degree and doctorate degree from McGill University.
Cargos activos de Reid Bissonnette
| Empresas | Cargo | Inicio |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Reid Bissonnette.
| Empresas | Cargo | Fin |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Targazyme, Inc.
Targazyme, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals to improve clinical efficacy and safety in stem cell transplantation, immunotherapy for cancer, regenerative medicine and gene therapy | Corporate Officer/Principal | - |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Corporate Officer/Principal | - |
| ARRIVENT BIOPHARMA, INC. | Corporate Officer/Principal | - |
Formación de Reid Bissonnette.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Ligand Pharmaceuticals, Inc.
Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Targazyme, Inc.
Targazyme, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals to improve clinical efficacy and safety in stem cell transplantation, immunotherapy for cancer, regenerative medicine and gene therapy | Health Technology |
Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
Arrivent BioPharma, Inc.
Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
- Bolsa de valores
- Insiders
- Reid Bissonnette
















